Argenx Shares Jump After Positive Phase 3 Results in Autoimmune Myositis Trial

3-line summary

• Argenx shares jumped after the company reported positive Phase 3 results in an autoimmune myositis clinical trial, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.